CSNK1A1 and medulloblastoma: Mutations of DDX3X, which have been identified in medulloblastoma patients, increased the activity of CK1 in living cells, which led to aberrant stimulation of CK1-mediated pathways (such as Wnt/β-catenin signaling) [181].